Skip to main content
. 2021 May 18;2(5):100289. doi: 10.1016/j.xcrm.2021.100289

Figure 3.

Figure 3

The effect of oseltamivir on immunocompromised mice

(A and B) Corticosteroid-treated C57BL/6J mice were treated with PBS or oseltamivir (10 mg/kg) twice daily for 5 days and infected with A. fumigatus (1 × 107) via the intranasal route.

(A) Kaplan-Meier survival plot of mice infected with A. fumigatus. Results were derived from three independent experiments (total n = 24 mice per group).

(B) Fungal burden in lung homogenates of mice on day 2 after infection. ∗∗∗p < 0.001.

(C and D) BALB/c mice were treated with oseltamivir (10 mg/kg, n = 10) or PBS (n = 10) twice per day for 5 days and infected intranasally with A. fumigatus. Immunosuppression was induced by intraperitoneal administration of cyclophosphamide (150 mg/kg). Shown are Kaplan-Meier survival plot (C) from mice after 3 days of infection and fungal burden (D) measured from lung homogenates.